136 related articles for article (PubMed ID: 15728931)
1. Efg1 involved in drug resistance by regulating the expression of ERG3 in Candida albicans.
Lo HJ; Wang JS; Lin CY; Chen CG; Hsiao TY; Hsu CT; Su CL; Fann MJ; Ching YT; Yang YL
Antimicrob Agents Chemother; 2005 Mar; 49(3):1213-5. PubMed ID: 15728931
[TBL] [Abstract][Full Text] [Related]
2. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
3. Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
Lo HJ; Tseng KY; Kao YY; Tsao MY; Lo HL; Yang YL
Int J Antimicrob Agents; 2015 Jun; 45(6):617-21. PubMed ID: 25802233
[TBL] [Abstract][Full Text] [Related]
4. Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells.
Yang YL; Wang CW; Chen CT; Wang MH; Hsiao CF; Lo HJ
Mycol Res; 2009 Mar; 113(Pt 3):388-90. PubMed ID: 19111931
[TBL] [Abstract][Full Text] [Related]
5. Non-lethal Candida albicans cph1/cph1 efg1/efg1 transcription factor mutant establishing restricted zone of infection in a mouse model of systemic infection.
Chen CG; Yang YL; Cheng HH; Su CL; Huang SF; Chen CT; Liu YT; Su IJ; Lo HJ
Int J Immunopathol Pharmacol; 2006; 19(3):561-5. PubMed ID: 17026841
[TBL] [Abstract][Full Text] [Related]
6. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.
Chamilos G; Lionakis MS; Lewis RE; Lopez-Ribot JL; Saville SP; Albert ND; Halder G; Kontoyiannis DP
J Infect Dis; 2006 Apr; 193(7):1014-22. PubMed ID: 16518764
[TBL] [Abstract][Full Text] [Related]
7. Deletion of EFG1 promotes Candida albicans opaque formation responding to pH via Rim101.
Nie X; Liu X; Wang H; Chen J
Acta Biochim Biophys Sin (Shanghai); 2010 Oct; 42(10):735-44. PubMed ID: 20870932
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium.
Korting HC; Hube B; Oberbauer S; Januschke E; Hamm G; Albrecht A; Borelli C; Schaller M
J Med Microbiol; 2003 Aug; 52(Pt 8):623-632. PubMed ID: 12867554
[TBL] [Abstract][Full Text] [Related]
9. Loss of Upc2p-Inducible
Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
mBio; 2018 May; 9(3):. PubMed ID: 29789366
[TBL] [Abstract][Full Text] [Related]
10. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi.
Stoldt VR; Sonneborn A; Leuker CE; Ernst JF
EMBO J; 1997 Apr; 16(8):1982-91. PubMed ID: 9155024
[TBL] [Abstract][Full Text] [Related]
11. In vitro reconstructed human epithelia reveal contributions of Candida albicans EFG1 and CPH1 to adhesion and invasion.
Dieterich C; Schandar M; Noll M; Johannes FJ; Brunner H; Graeve T; Rupp S
Microbiology (Reading); 2002 Feb; 148(Pt 2):497-506. PubMed ID: 11832513
[TBL] [Abstract][Full Text] [Related]
12. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans.
Prasad T; Hameed S; Manoharlal R; Biswas S; Mukhopadhyay CK; Goswami SK; Prasad R
FEMS Yeast Res; 2010 Aug; 10(5):587-96. PubMed ID: 20491944
[TBL] [Abstract][Full Text] [Related]
13. Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes.
Pierce JV; Dignard D; Whiteway M; Kumamoto CA
Eukaryot Cell; 2013 Jan; 12(1):37-49. PubMed ID: 23125349
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicans.
Chau AS; Gurnani M; Hawkinson R; Laverdiere M; Cacciapuoti A; McNicholas PM
Antimicrob Agents Chemother; 2005 Sep; 49(9):3646-51. PubMed ID: 16127034
[TBL] [Abstract][Full Text] [Related]
16. DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida albicans.
Lane S; Birse C; Zhou S; Matson R; Liu H
J Biol Chem; 2001 Dec; 276(52):48988-96. PubMed ID: 11595734
[TBL] [Abstract][Full Text] [Related]
17. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
[TBL] [Abstract][Full Text] [Related]
18. Serum repressing efflux pump CDR1 in Candida albicans.
Yang YL; Lin YH; Tsao MY; Chen CG; Shih HI; Fan JC; Wang JS; Lo HJ
BMC Mol Biol; 2006 Jul; 7():22. PubMed ID: 16839415
[TBL] [Abstract][Full Text] [Related]
19. The role of secreted aspartyl proteinases in Candida albicans keratitis.
Jackson BE; Wilhelmus KR; Hube B
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3559-65. PubMed ID: 17652724
[TBL] [Abstract][Full Text] [Related]
20. Co-regulation of pathogenesis with dimorphism and phenotypic switching in Candida albicans, a commensal and a pathogen.
Liu H
Int J Med Microbiol; 2002 Oct; 292(5-6):299-311. PubMed ID: 12452278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
